Tetraviral Vaccine

Tetravalent vaccine containing measles, mumps, rubella and varicella · Bio-Manguinhos/Fiocruz

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Tetraviral Vaccine, covering 2016-07-11 to 2016-07-11. Get the full timeline:

Most recent: Clinical Trial Update: Study of Immunogenicity, Reactogenicity and Safety of the Combined Measles, Mumps and Rubella Vaccine Produced by Bio-Manguinhos/Fiocruz in Children 12-15 Months of Age, Followed by Tetraviral Vaccine in Children 15-18 Months. [Phase 3]

See pricing